Elite Pharmaceuticals (ELTP) EV to CFO (2011 - 2026)
Elite Pharmaceuticals' EV to CFO came in at 18.86 for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 52.6% from 39.80 a year earlier but up 25.3% from the prior quarter.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) EV to CFO (2011 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Elite Pharmaceuticals reported EV to CFO of 14.72, down 61.5% year-over-year; for FY2026 (ended Mar 31, 2026), it was 15.05, down 75.5% from FY2025.
- Going back by fiscal year, EV to CFO was 61.47 in FY2025, 6.64 in FY2023 (+98.2%) and 3.35 in FY2022 (-81.3%).
- The five-year range for quarterly EV to CFO is 3.35 (fiscal Q4 2022) to 100.78 (fiscal Q3 2025).
- Year-over-year, EV to CFO has declined for five consecutive quarters, with an average decline of 63.9% over the last five quarters.
- The fastest year-over-year change in EV to CFO over five years came in fiscal Q1 2025 (growth of 198.6%), and the weakest in fiscal Q4 2022 (a decline of 81.3%).
- Business Quant data shows ELTP's EV to CFO at 15.05 (Q4 2026), 27.33 (Q3 2026) and 29.06 (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn |
| 10 | Elite Pharmaceuticals | 258.43 Mn | 140.10 Mn | 13.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.86 |
| Mar 31, 2026 | 15.05 |
| Dec 31, 2025 | 27.33 |
| Sep 30, 2025 | 29.06 |
| Jun 30, 2025 | 39.80 |
| Mar 31, 2025 | 61.47 |
| Dec 31, 2024 | 100.78 |
| Sep 30, 2024 | 94.30 |
| Jun 30, 2024 | 78.20 |
| Jun 30, 2023 | 26.18 |
| Mar 31, 2023 | 6.64 |
| Dec 31, 2022 | 6.33 |
| Sep 30, 2022 | 3.95 |
| Jun 30, 2022 | 11.94 |
| Mar 31, 2022 | 3.35 |
| Dec 31, 2021 | 5.55 |
| Sep 30, 2021 | 15.27 |
| Jun 30, 2021 | 11.17 |
| Mar 31, 2021 | 17.96 |
| Dec 31, 2020 | 16.46 |
API Access
Elite Pharmaceuticals EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();